PCA
BIIB icon

Private Capital Advisors’s Biogen BIIB Stock Holding History

Private Capital Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-884
Closed -$205K – 79
2024
Q2 		$205K Buy
+884
New +$192K 0.02% 75
2024
Q1 		– Sell
-884
Closed -$229K – 87
2023
Q4 		$229K Hold
884
– – 0.03% 72
2023
Q3 		$210K Buy
+884
New +$236K 0.03% 82
2014
Q1 		– Sell
-14,675
Closed -$4.1M – 103
2013
Q4 		$4.1M Buy
14,675
+10,675
+267% +$2.76M 1.4% 29
2013
Q3 		$963K Buy
+4,000
New +$895K 0.35% 72

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Private Capital Advisors's BIIB Position: Q3 2024 in Review

Private Capital Advisors sold out of Biogen (BIIB) in Q3 2024, closing a stake of 884 shares — an estimated $205K sold.

Private Capital Advisors first reported a position in BIIB in Q3 2013 and held it in 5 quarters. The position peaked at $4.1M in Q4 2013. 917 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

  • Private Capital Advisors reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
  • Private Capital Advisors sold 884 Biogen shares in Q3 2024, an estimated $205K.
  • Private Capital Advisors first reported a position in Biogen in Q3 2013 and held it in 5 quarters.
  • Private Capital Advisors's Biogen position peaked at $4.1M in Q4 2013.
  • 917 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Private Capital Advisors's 13F filing for Q3 2024, filed 4 Nov 2024.